Work

An Open-Label, Phase II Study Evaluating the Safety and Efficacy of PTK787/ZK222584 in Patients With Metastatic Neuroendocrine Tumors That Have Evidence of Progressive Disease or an Increase in Disease Related Syndrome Symptoms

Year: 2010

Type: article

Study design: Clinical Trial

Source: Pancreas

DOI: 10.1097/mpa.0b013e3181c8fc3e

Authors: Lowell B. Anthony, Maria M. Chester, Bernard J. Brown, Stacy L. Michael, Jacky R. Seward, M. Sue O'Dorisio, Thomas M. O'Dorisio

Institutions: Louisiana State University Health Sciences Center New Orleans, University of Iowa

Language: English

Topic: Neuroendocrine Tumor Research Advances

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2081738069

FWCI: 0.233

Cites:

Cited by: 1

Related to: 10